Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Auvelity™ (dextromethorphan/bupropion) – New drug approval
August 19, 2022 - Axsome Therapeutics announced the FDA approval of Auvelity (dextromethorphan/bupropion), for the treatment of major depressive disorder (MDD) in adults.
